The Korean Journal of Medicine

  • 제80권4호
  • /
  • Pages.477-481
  • /
  • 2011
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지

신경섬유종증 2형에 동반된 유방암 1예

Case of Breast Cancer in a Neurofibromatosis 2 Patient

  • 안세진 (한국원자력의학원 원자력병원 내과) ;
  • 강혜진 (한국원자력의학원 원자력병원 내과) ;
  • 이승숙 (한국원자력의학원 원자력병원 병리과) ;
  • 양기영 (한국원자력의학원 원자력병원 내과) ;
  • 이태현 (한국원자력의학원 원자력병원 영상의학과) ;
  • 이종환 (한국원자력의학원 원자력병원 내과) ;
  • 김형진 (한국원자력의학원 원자력병원 내과)
  • Ahn, Se-Jin (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Kang, Hye-Jin (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Lee, Seung-Sook (Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Yang, Gi-Young (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Lee, Tae-Hyeon (Department of Radiology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Lee, Jong-Hwan (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Kim, Hyung-Jin (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences)
  • 발행 : 2011.04.01
⟨ 이전 논문 다음 논문 ⟩

초록

저자들은 신경섬유종증 2형에 동반된 46세 여자 환자의 유방암 1예를 경험하였기에 문헌고찰과 함께 보고하고자 하는 바이다. 신경섬유종증 2형과 유방암과의 연관성이 아직 명확히 밝혀지지 않았으나, 신경섬유종증 2형에 동반될 수 있는 악성 종양으로 유방암이 발생할 수 있고 더 강한 침습성과 나쁜 예후의 가능성이 있음을 고려해야 할 것으로 생각한다.

Neurofibromatosis 2 is a multiple neoplasia syndrome that is caused by mutations in the NF2 tumor suppressor gene on chromosome 22q12. Bilateral vestibular nerve schwannomas are the distinctive feature of neurofibromatosis 2. There have been no reported cases of breast cancer in patients with neurofibromatosis 2. We recently encountered a case of breast cancer in a 46-year-old woman with neurofibromatosis 2. She had had a palpable right beast mass for the previous year andtinnitus in her left ear for the previous 6 months. She was diagnosed with breast cancer (invasive ductal carcinoma) with metastasis to the lungs, bones and stomach. MRI of the brain revealed nodules in both internal auditory canals, indicating that she was suffering from neurofibromatosis 2. After radiation therapy for compression fractures in T8 and L1, and one cycle of chemotherapy, the patient died of febrile neutropenia and pneumonia.

키워드

참고문헌

  1. Evans DG, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-846. https://doi.org/10.1136/jmg.29.12.841
  2. Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 2005;26:93-97. https://doi.org/10.1097/00129492-200501000-00016
  3. Asthagiri AR, Parry DM, Butman JA, et al. Neurofibromatosis type 2. Lancet 2009;373:1974-1986. https://doi.org/10.1016/S0140-6736(09)60259-2
  4. Dai JL, Wang L, Sahin AA, Broemeling LD, Schutte M, Pan Y. NHERF ($Na^+/H^+$ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 2004;23:8681-8687. https://doi.org/10.1038/sj.onc.1207962
  5. Seizinger BR, Martuza RL, Gusella JF. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 1986;322:644-647. https://doi.org/10.1038/322644a0
  6. Rouleau GA, Wertelecki W, Haines JL, et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 1987;329:246-248. https://doi.org/10.1038/329246a0
  7. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane organizing protein causes neurofibromatosis type 2. Nature 1993;363:515-521. https://doi.org/10.1038/363515a0
  8. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800. https://doi.org/10.1016/0092-8674(93)90406-G
  9. Takeshima H, Izawa I, Lee PS, Safdar N, Levin VA, Saya H. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene 1994;9:2135-2144.
  10. Beckmann MW, Niederacher D, Schnürch HG, Gusterson BA. Bender HG. Multistep carcinogenesis of breast cancer and tumor heterogeneity. J Mol Med 1997;75:429-439. https://doi.org/10.1007/s001090050128
  11. Bianchi AB, Hara T, Ramesh V, et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 1994;6:185-192. https://doi.org/10.1038/ng0294-185
  12. Cooupman PJ, Do MT, Barth M, et al. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 2000;406:742-747. https://doi.org/10.1038/35021086
  13. Yuan Y, Mendez R, Sahin A, Dai JL. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 2001;61:5558-5561.
  14. Toyama T, Iwase H, Yamashita H, et al. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 2002;189:97-102.